Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH). The gene discussed is SLC5A2; the disease is metabolic dysfunction-associated steatohepatitis.